Cargando…
CD276 is an important player in macrophage recruitment into the tumor and an upstream regulator for PAI-1
More than 70% of colorectal, prostate, ovarian, pancreatic and breast cancer specimens show expression of CD276 (B7–H3), a potential immune checkpoint family member. Several studies have shown that high CD276 expression in cancer cells correlates with a poor clinical prognosis. This has been associa...
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group UK
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8295264/ https://www.ncbi.nlm.nih.gov/pubmed/34290311 http://dx.doi.org/10.1038/s41598-021-94360-9 |